D. Western Therapeutics Institute (TSE:4576) EV-to-EBIT : -3.24 (As of Dec. 13, 2024)

D. Western Therapeutics Institute EV-to-EBIT Chart

D. Western Therapeutics Institute Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-EBIT		Get a 7-Day Free Trial					138.64	-23.19	-30.76	-15.41	-4.30

D. Western Therapeutics Institute Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
EV-to-EBIT	Get a 7-Day Free Trial															-9.03	-7.06	-4.30	-3.69	-2.60

Competitive Comparison of D. Western Therapeutics Institute's EV-to-EBIT

For the Biotechnology subindustry, D. Western Therapeutics Institute's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

D. Western Therapeutics Institute's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, D. Western Therapeutics Institute's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where D. Western Therapeutics Institute's EV-to-EBIT falls into.

D. Western Therapeutics Institute EV-to-EBIT Calculation

D. Western Therapeutics Institute's EV-to-EBIT for today is calculated as:

D. Western Therapeutics Institute's current Enterprise Value is 円3,529.5 Mil.
D. Western Therapeutics Institute's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-1,088.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D. Western Therapeutics Institute  (TSE:4576) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

D. Western Therapeutics Institute's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

D. Western Therapeutics Institute's Enterprise Value for the quarter that ended in Jun. 2024 was 円2,826.9 Mil.
D. Western Therapeutics Institute's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-1,088.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D. Western Therapeutics Institute EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of D. Western Therapeutics Institute's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

D. Western Therapeutics Institute Business Description